Accuracy and Precision of Noninvasive Blood Pressure in Normo-, Hyper-, and Hypotensive Standing and Anesthetized Adult Horses

BACKGROUND: Blood pressure is relevant to the diagnosis and management of many medical, cardiovascular and critical diseases. The accuracy of many commonly used noninvasive blood pressure (NIBP) monitors and the accuracy of NIBP measurements in hypo‐ and hypertensive standing horses has not been determined. HYPOTHESIS/OBJECTIVES: The objective of this study was to investigate the accuracy of an oscillometric BP monitor in standing horses before and during pharmacologically induced hyper‐ and hypotension and to compare results in standing and anesthetized horses. ANIMALS: Eight standing mares from a research herd (SG) and eight anesthetized horses from a hospital population (AG). METHODS: Prospective experimental and observational studies. Invasive blood pressure (IBP) and NIBP, corrected to heart level, were measured simultaneously. In the SG hyper‐ and hypotension were induced by administration of phenylephrine (3 μg/kg/min IV for 15 minutes) and acepromazine (0.05 mg/kg IV), respectively. In the AG NIBP and IBP were recorded during regular hospital procedures. RESULTS: There was a significant correlation between mean NIBP and IBP in standing (R = 0.88, P < .001) and anesthetized horses (R = 0.81, P < .001). The mean bias (lower, upper limit of agreement) was 16.4(−16.1, 48.9) mmHg for mean BP in the SG and 0.5(−22.3, 23.2) mmHg in the AG. The NIBP device was capable of identifying the increase and decrease in BP in all horses, but in the SG significant correlation between NIBP and IBP was only detected for the normotensive phase. CONCLUSION AND CLINICAL IMPORTANCE: While the evaluated oscillometric BP device allowed estimation of BP and adequately differentiated marked trends, the accuracy and precision were low in standing horses

Cardiovascular variables in eventing and endurance horses over a season

Introduction The objectives of this study were to describe the changes in clinical cardiovascular examination variables over a competition season in groups of competitive eventing and endurance horses and to compare these findings to non-competitive controls of the same breeds. Animals This study included two eventing horses, 11 endurance horses, and 13 eventing and seven endurance control breed-matched horses. Materials and methods Cardiovascular examinations were performed before starting the competition season, in the middle and at the peak/end of the competition season. Examinations included auscultation of the heart; M-mode echocardiographic measurements and calculated values; left atrial, pulmonary artery, and aortic diameters; color flow Doppler; exercise electrocardiograms (ECG) measuring peak heart rates and quantifying premature complexes; and 24-h continuous ECGs quantifying premature complexes per hour. Results Auscultation, echocardiograms, arrhythmias during exercise, and 24-h continuous ECGs did not change significantly throughout the season (p > 0.05 for all variables). Conclusion Cardiovascular examination variables of eventing and endurance horses throughout a competition season are reported here for the first time. Although the present study did not reveal significant changes, data should be interpreted carefully as only a small number of horses were examined

Atrial fibrillation management in a breeding stallion.

A 20-year-old warmblood breeding stallion presented to a University practice for semen collection and evaluation was incidentally diagnosed with atrial fibrillation (AF). Electrocardiogram recordings during breeding revealed inappropriately rapid tachycardia and occasional ventricular premature depolarizations/aberrant ventricular conduction. Transvenous electrical cardioversion was performed. After successful cardioversion the horse displayed supraventricular ectopy and atrial contractile dysfunction and was administered sotalol hydrochloride in an attempt to decrease the risk of AF recurrence. Supraventricular ectopy and echocardiographic evidence of atrial dysfunction gradually improved and normalized over 6 months. No direct adverse effects of the chronic anti-arrhythmic treatment were observed and libido and semen quality were unaffected. AF recurred 6 months after cardioversion and sotalol therapy was continued to control the ventricular ectopy/aberrant ventricular conduction during semen collection. Considerations regarding pathologic arrhythmias and inappropriately high heart rates in breeding stallions with AF may be similar to those in riding horses. Sotalol hydrochloride was a safe anti-arrhythmic drug in the management of this case